Breakthrough T1D and Gore Invest in Development of Implantable Insulin Delivery System
PhysioLogic Devices, a Breakthrough T1D-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to develop the ThinPump™—a fully implantable automated insulin delivery system—in the next four years. We think it’s not only possible, but doable. PhysioLogic has two things going for it: Gore is well known for developing GORE-TEX […]
